Margolis, David J.
Mitra, Nandita
Hoffstad, Ole J.
Berna, Ronald
Kim, Brian S.
Chopra, Abha
Phillips, Elizabeth J.
Funding for this research was provided by:
National Institutes of Health (AR060962)
Pfizer
Article History
Received: 16 September 2022
Accepted: 25 January 2023
First Online: 31 January 2023
Competing interests
: David Margolis is or recently has been a consultant for Pfizer, Leo, and Sanofi with respect to studies of atopic dermatitis and served on an advisory board for the National Eczema Association. The other authors do not report potential conflicts of interest with respect to the materials in this manuscript.